BioRestorative Therapies, Inc.

BRTXNASDAQHealthcare● Active

$0.36

$-0.04(-10.62%)

Market Cap$3255285

P/E Ratio—

52W High$2.045

52W Low$0.1593

Avg Volume13.8M

Open$0.40

Beta0.58

Overview

BioRestorative Therapies, Inc. (BRTX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · BRTX · as of Mar 26, 2026

Latest filing snapshot

+3+27.27%vs prior year

BioRestorative Therapies, Inc. (BRTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

Growth % (1Y)

+27.27%

Revenue / Employee

$25.7K

Net Income / Employee

$-1.02M

Market Cap

$3M

BRTX Employee Count

2011 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-26	2025-12-31	14	+3	+27.27%
2025-03-28	2024-12-31	11	+0	+0.00%
2024-04-01	2023-12-31	11	+1	+10.00%
2023-03-27	2022-12-31	10	+3	+42.86%
2022-03-30	2021-12-31	7	+2	+40.00%
2021-04-30	2020-12-31	5	-1	-16.67%
2021-03-18	2019-12-31	6	-3	-33.33%
2019-03-29	2018-12-31	9	+0	+0.00%
2018-04-02	2017-12-31	9	-2	-18.18%
2017-03-22	2016-12-31	11	+0	+0.00%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Bolt Biotherapeutics, Inc.

BioRestorative Therapies, Inc.YOU

14$3M

DWTX

Dogwood Therapeutics, Inc.

12$3M

COCP

Cocrystal Pharma, Inc.

11$10M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · BRTX peer comparison

About BRTX employees

BRTX Employees · Headcount

BioRestorative Therapies, Inc. (BRTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, BioRestorative Therapies, Inc. had 14 full-time employees globally. Full-time employees only. Global consolidated headcount.

BioRestorative Therapies, Inc. employs 14 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $25,693, reflecting the company's operational efficiency.

BioRestorative Therapies, Inc.'s workforce increased by 3 (27.27%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

BioRestorative Therapies, Inc.'s revenue per employee of $25,693 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

BRTX Employees · 5 questions

As of the latest SEC 10-K filing (2025), BioRestorative Therapies, Inc. had 14 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

BioRestorative Therapies, Inc. employee counthow many employees does BioRestorative Therapies, Inc. haveBRTX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-26